Iodixanol compared to iohexol for contrast procedures: A case-matched retrospective cohort study

Acta Radiologica

Volumn 49, Issue 4, 2008, Pages 409-414

  From, A M ^a   Bartholmai, B J ^a   Williams, A W ^a   McDonald, F S ^a  

^a MAYO CLINIC   (United States)

Author keywords

Contrast; Contrast nephropathy; Iodixanol; Iohexol

Indexed keywords

DISEASES; PATIENT TREATMENT; TOXICITY;

CONTRAST NEPHROPATHY; IODIXANOL; IOHEXOL;

DRUG PRODUCTS;

CONTRAST MEDIUM; CREATININE; DIAGNOSTIC AGENT; IODIXANOL; IODOBENZOIC ACID DERIVATIVE; IOHEXOL;

AGED; ANGIOGRAPHY; ARTICLE; CASE CONTROL STUDY; CHEMICALLY INDUCED DISORDER; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY DISEASE; MALE; PROPORTIONAL HAZARDS MODEL; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; STATISTICAL MODEL; URINE;

AGED; ANGIOGRAPHY; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CONTRAST MEDIA; CREATININE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; IOHEXOL; KIDNEY DISEASES; LOGISTIC MODELS; MALE; PROPORTIONAL HAZARDS MODELS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; TRIIODOBENZOIC ACIDS;

EID: 42949148139     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.1080/02841850801901791     Document Type: Article

References (28)

1. Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality. A cohort analysis. JAMA 1996;275:1489-94.
2. Marenzi G, Assanelli E, Marana I, Lauri G, Campodonico J, Grazi M, et al. N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med 2006;354:2773-82.
3. McCullough PA, Bertrand ME, Brinker JA, Stacul F. A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media. J Am Coll Cardiol 2006;48:692-9.
4. Aspelin P, Aubry P, Fransson SG, Strasser R, Will-enbrock R, Berg KJ, et al. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 2003;348:491-9.
5. Pugh ND, Sissons GR, Ruttley MS, Berg KJ, Nossen JO, Eide H. Iodixanol in femoral arteriography (phase III): a comparative double-blind parallel trial between iodixanol and iopromide. Clin Radiol 1993;47:96-9.
6. Andersen PE, Bolstad B, Berg KJ, Justesen P, Thayssen P, Kloster YF. Iodixanol and ioxaglate in cardioangiography: a double-blind randomized phase III study. Clin Radiol 1993;48:268-72.
7. Bertrand ME, Esplugas E, Piessens J, Rasch W. Influence of a nonionic, iso-osmolar contrast medium (iodixanol) versus an ionic, low-osmolar contrast medium (ioxaglate) on major adverse cardiac events in patients undergoing percutaneous transluminal coronary angioplasty: a multicenter, randomized, double-blind study. Visipaque in Percutaneous Transluminal Coronary Angioplasty [VIP] Trial Investigators. Circulation 2000;101:131-6.
8. Hill JA, Cohen MB, Kou WH, Mancini GB, Mansour M, Fountaine H, et al. Iodixanol, a new isosmotic nonionic contrast agent compared with iohexol in cardiac angiography. Am J Cardiol 1994;74:57-63.
9. Klow NE, Levorstad K, Berg KJ, Brodahl U, Endresen K, Kristoffersen DT, et al. Iodixanol in cardioangiography in patients with coronary artery disease. Tolerability, cardiac and renal effects. Acta Radiol 1993;34: 72-7.
10. Jakobsen JA. Renal effects of iodixanol in healthy volunteers and patients with severe renal failure. Acta Radiol Suppl 1995;399:191-5.
11. Siegel EL, Rosenblum JD, Eckard DA, Leef J, Bergh J, Parsa MB, et al. Comparison of iodixanol and ioxaglate for adult aortography and renal/visceral angiography: a phase III clinical trial. Acad Radiol 1996;3(Suppl 3): S507-13.
12. Liss P, Persson P, Hansell P, Lagergvist B. Renal failure in 57925 patients undergoing coronary procedures using iso-osmolar or low-osmolar contrast media. Kidney Int 2006;70:1811-7.
13. McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 1997;103:368-75.
14. Hou SH, Bushinsky DA, Wish JB, Cohen JJ, Harrington JT. Hospital-acquired renal insufficiency: a prospective study. Am J Med 1983;74:243-8.
15. Pannu N, Wiebe N, Tonelli M, Alberta Kidney Disease Network. Prophylaxis strategies for contrast-induced nephropathy. JAMA 2006;295:2765-79.
16. Kandzari DE, Rebeiz AG, Wang A, Sketch MH Jr. Contrast nephropathy: an evidence-based approach to prevention. Am J Cardio Drug 2003;3:395-405.
17. Maeder M, Klein M, Fehr T, Rickli H. Contrast nephropathy: review focusing on prevention, J Am Coll Cardiol 2004;44:1763-71.
18. Merten GJ, Burgess WP, Gray LV, Holleman JH, Roush TS, Kowalchuk GJ, et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 2004;291:2328-34.
19. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006;355:251-9.
20. Roger VL, Weston SA, Redfield MM, Hellermann-Homan JP, Killian J, Yawn BP, et al. Trends in heart failure incidence and survival in a community-based population. JAMA 2004;292:344-50.
21. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation, Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-70.
22. Poggio ED, Wang X, Weinstein DM, Issa N, Dennis VW, Braun WE, et al. Assessing glomerular filtration rate by estimation equations in kidney transplant recipients. Am J Transpl 2006;6:100-8.
23. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39: S1-266.
24. Grossman RI, Modic MT. A randomized comparison of iodixanol and iohexol in adult intracranial computed tomography scanning. Acad Radiol 1996;3(Suppl 3): S488-94.
25. Verow P, Nossen JO, Sheppick A, Kjaersgaard P. A comparison of iodixanol with iopamidol in aortofemoral angiography. Br J Radiol 1995;68:973-8.
26. Poirier VC, Newberry PD, Hecht ST, Nemzek WR. Phase III clinical trial comparing iodixanol and iohexol in cerebral angiography. Acad Radiol 1996;3(Suppl 3): S495-9.
27. Tveit K, Bolz KD, Bolstad B, Haugland T, Berg KJ, Skjaerpe T, et al. Iodixanol in cardioangiography. A double-blind parallel comparison between iodixanol 320 mg I/ml and ioxaglate 320 mg I/ml. Acta Radiol 1994; 35:614-8.
28. Singh K, Sundgren R, Bolstad B, Bjork L, Lie M. Iodixanol in abdominal digital subtraction angiography. A randomized, double-blind, parallel trial with iodixanol and iohexol. Acta Radiol 1993;34:242-5.